CompuMed Inc. reported earnings results for the third quarter of 2015. For the quarter, the company achieved a 34% increase in revenue. The company's sales increased significantly across all major product and service lines.

Earnings before interest taxes depreciation amortization increased more than four times that of EBITDA in the same quarter from the previous year. The company's quarterly growth was driven in part by a 295% increase in ultrasound interpretation revenue and a 74% increase in teleradiology revenue. These residual revenue streams are expected to be key growth areas for the company in future quarters.